170 related articles for article (PubMed ID: 30680866)
21. Uptake, Results, and Outcomes of Germline Multiple-Gene Sequencing After Diagnosis of Breast Cancer.
Kurian AW; Ward KC; Hamilton AS; Deapen DM; Abrahamse P; Bondarenko I; Li Y; Hawley ST; Morrow M; Jagsi R; Katz SJ
JAMA Oncol; 2018 Aug; 4(8):1066-1072. PubMed ID: 29801090
[TBL] [Abstract][Full Text] [Related]
22. What made her give up her breasts: a qualitative study on decisional considerations for contralateral prophylactic mastectomy among breast cancer survivors undergoing BRCA1/2 genetic testing.
Kwong A; Chu AT
Asian Pac J Cancer Prev; 2012; 13(5):2241-7. PubMed ID: 22901201
[TBL] [Abstract][Full Text] [Related]
23. Impact of genetic counseling on the uptake of contralateral prophylactic mastectomy among younger women with breast cancer.
Terkelsen T; Rønning H; Skytte AB
Acta Oncol; 2020 Jan; 59(1):60-65. PubMed ID: 31379231
[No Abstract] [Full Text] [Related]
24. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium.
Burke W; Daly M; Garber J; Botkin J; Kahn MJ; Lynch P; McTiernan A; Offit K; Perlman J; Petersen G; Thomson E; Varricchio C
JAMA; 1997 Mar; 277(12):997-1003. PubMed ID: 9091675
[TBL] [Abstract][Full Text] [Related]
25. Analysis of hereditary cancer syndromes by using a panel of genes: novel and multiple pathogenic mutations.
Tsaousis GN; Papadopoulou E; Apessos A; Agiannitopoulos K; Pepe G; Kampouri S; Diamantopoulos N; Floros T; Iosifidou R; Katopodi O; Koumarianou A; Markopoulos C; Papazisis K; Venizelos V; Xanthakis I; Xepapadakis G; Banu E; Eniu DT; Negru S; Stanculeanu DL; Ungureanu A; Ozmen V; Tansan S; Tekinel M; Yalcin S; Nasioulas G
BMC Cancer; 2019 Jun; 19(1):535. PubMed ID: 31159747
[TBL] [Abstract][Full Text] [Related]
26. Collaboration of breast cancer clinic and genetic counseling division for BRCA1 and BRCA2 mutation family in Japan.
Takeda M; Ishida T; Ohnuki K; Suzuki A; Sakayori M; Ishioka C; Nomizu T; Noguchi S; Matsubara Y; Ohuchi N
Breast Cancer; 2004; 11(1):30-2. PubMed ID: 14718789
[TBL] [Abstract][Full Text] [Related]
27. Breast cancer genetic counseling after diagnosis but before treatment: a pilot study on treatment consequences and psychological impact.
Wevers MR; Hahn DE; Verhoef S; Bolhaar MD; Ausems MG; Aaronson NK; Bleiker EM
Patient Educ Couns; 2012 Oct; 89(1):89-95. PubMed ID: 22543000
[TBL] [Abstract][Full Text] [Related]
28. Influence of race/ethnicity on genetic counseling and testing for hereditary breast and ovarian cancer.
Forman AD; Hall MJ
Breast J; 2009; 15 Suppl 1():S56-62. PubMed ID: 19775331
[TBL] [Abstract][Full Text] [Related]
29. Breast cancer in transgender female-to-male individuals: A case report of androgen receptor-positive breast cancer.
Fundytus A; Saad N; Logie N; Roldan Urgoiti G
Breast J; 2020 May; 26(5):1007-1012. PubMed ID: 31749246
[TBL] [Abstract][Full Text] [Related]
30. Difficulties of gender affirming treatment in trans women with BRCA1+ mutation: A case report.
Piñar-Gutiérrez A; Dueñas Disotuar S; de Lara-Rodríguez I; Amuedo-Domínguez S; González-Cejudo C; Tejero-Delgado J; Mangas-Cruz MÁ
Endocrinol Diabetes Nutr (Engl Ed); 2024 Mar; 71(3):144-148. PubMed ID: 38555112
[TBL] [Abstract][Full Text] [Related]
31. Medical knowledge and information needs among women with pathogenic variants in moderate-risk genes for hereditary breast cancer attending genetic counseling at an academic hospital in Germany-A qualitative approach.
Stracke C; Lemmen C; Rhiem K; Schmutzler R; Kautz-Freimuth S; Stock S
J Genet Couns; 2022 Jun; 31(3):698-712. PubMed ID: 34837291
[TBL] [Abstract][Full Text] [Related]
32. Initial experience with surgical treatment planning in the newly diagnosed breast cancer patient at high risk for BRCA-1 or BRCA-2 mutation.
Stolier AJ; Fuhrman GM; Mauterer L; Bolton JS; Superneau DW
Breast J; 2004; 10(6):475-80. PubMed ID: 15569201
[TBL] [Abstract][Full Text] [Related]
33. Interdisciplinary Management of Transgender Individuals at Risk for Breast Cancer: Case Reports and Review of the Literature.
Eismann J; Heng YJ; Fleischmann-Rose K; Tobias AM; Phillips J; Wulf GM; Kansal KJ
Clin Breast Cancer; 2019 Feb; 19(1):e12-e19. PubMed ID: 30527351
[No Abstract] [Full Text] [Related]
34. Psychosocial aspects of genetic counseling and testing.
Vadaparampil ST; Wey JP; Kinney AY
Semin Oncol Nurs; 2004 Aug; 20(3):186-95. PubMed ID: 15491028
[TBL] [Abstract][Full Text] [Related]
35. Psychosocial and behavioral impact of genetic counseling and testing.
Vadaparampil ST; Miree CA; Wilson C; Jacobsen PB
Breast Dis; 2006-2007; 27():97-108. PubMed ID: 17917142
[TBL] [Abstract][Full Text] [Related]
36. Counseling the at risk patient in the BRCA1 and BRCA2 Era.
Barnes-Kedar IM; Plon SE
Obstet Gynecol Clin North Am; 2002 Jun; 29(2):341-66, vii. PubMed ID: 12108833
[TBL] [Abstract][Full Text] [Related]
37. Cancer Risk Information Sharing: The Experience of Individuals Receiving Genetic Counseling for BRCA1/2 Mutations.
Chopra I; Kelly KM
J Health Commun; 2017 Feb; 22(2):143-152. PubMed ID: 28112991
[TBL] [Abstract][Full Text] [Related]
38. Hereditary diffuse gastric cancer and lynch syndromes in a BRCA1/2 negative breast cancer patient.
Njoroge SW; Burgess KR; Cobleigh MA; Alnajar HH; Gattuso P; Usha L
Breast Cancer Res Treat; 2017 Nov; 166(1):315-319. PubMed ID: 28702897
[TBL] [Abstract][Full Text] [Related]
39. Predictors and outcomes of contralateral prophylactic mastectomy among breast cancer survivors.
Graves KD; Peshkin BN; Halbert CH; DeMarco TA; Isaacs C; Schwartz MD
Breast Cancer Res Treat; 2007 Sep; 104(3):321-9. PubMed ID: 17066320
[TBL] [Abstract][Full Text] [Related]
40. Impact of Genetic Counseling and Testing on Altruistic Motivations to Test for BRCA1/2: a Longitudinal Study.
Garg R; Vogelgesang J; Kelly K
J Genet Couns; 2016 Jun; 25(3):572-82. PubMed ID: 26578231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
